(ITGR) Integer Holdings - Ratings and Ratios
Implants, Batteries, Leads, Enclosures, Feedthroughs
ITGR EPS (Earnings per Share)
ITGR Revenue
Description: ITGR Integer Holdings
Integer Holdings Corporation is a leading medical device contract development and manufacturing company serving multi-national original equipment manufacturers (OEMs) in various medical markets, including cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company offers a diverse range of products, including implantable pacemakers, cardioverter defibrillators, spinal cord stimulators, and various other medical devices and components.
From a business perspective, Integer Holdings Corporation has a strong presence in the medical device industry, with a long history dating back to 1970. The company has undergone significant transformations, including a name change from Greatbatch, Inc. to Integer Holdings Corporation in 2016. Its diversified product portfolio and global manufacturing footprint, with operations in the United States, Puerto Rico, Costa Rica, and internationally, position it well for growth in the medical device market.
Key performance indicators (KPIs) that can be used to evaluate Integer Holdings Corporations financial health and operational efficiency include revenue growth, gross margin, operating margin, and return on equity (ROE). With a current ROE of 5.05%, the company may be considered to have a relatively modest return on equity. However, its forward P/E ratio of 19.96 suggests that investors expect future growth. Other relevant KPIs could include metrics such as customer concentration, product diversification, and research and development (R&D) investment as a percentage of revenue.
To further analyze Integer Holdings Corporations prospects, it would be essential to examine its revenue breakdown by market segment, geographic region, and product category. Additionally, assessing the companys competitive positioning, regulatory environment, and innovation pipeline could provide valuable insights into its potential for long-term success. With a market capitalization of approximately $3.79 billion, Integer Holdings Corporation is a mid-cap company with a relatively stable presence in the healthcare equipment industry.
ITGR Stock Overview
| Market Cap in USD | 3,708m |
| Sub-Industry | Health Care Equipment |
| IPO / Inception | 2000-09-29 |
ITGR Stock Ratings
| Growth Rating | 16.5% |
| Fundamental | 62.2% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -32.1% |
| Analyst Rating | 4.60 of 5 |
ITGR Dividends
Currently no dividends paidITGR Growth Ratios
| Growth Correlation 3m | -86.1% |
| Growth Correlation 12m | -78.2% |
| Growth Correlation 5y | 65.2% |
| CAGR 5y | 18.03% |
| CAGR/Max DD 3y | 0.59 |
| CAGR/Mean DD 3y | 4.00 |
| Sharpe Ratio 12m | -1.12 |
| Alpha | 0.18 |
| Beta | 0.129 |
| Volatility | 30.75% |
| Current Volume | 1036.4k |
| Average Volume 20d | 283.1k |
| Stop Loss | 99.9 (-3.1%) |
| Signal | 1.71 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (82.7m TTM) > 0 and > 6% of Revenue (6% = 107.7m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 2.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.05% (prev 28.22%; Δ 0.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 209.9m > Net Income 82.7m (YES >=105%, WARN >=100%) |
| Net Debt (1.30b) to EBITDA (196.8m) ratio: 6.60 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (35.7m) change vs 12m ago 0.52% (target <= -2.0% for YES) |
| Gross Margin 26.90% (prev 25.68%; Δ 1.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 55.25% (prev 53.39%; Δ 1.86pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.13 (EBITDA TTM 196.8m / Interest Expense TTM 51.3m) >= 6 (WARN >= 3) |
Altman Z'' 2.73
| (A) 0.15 = (Total Current Assets 737.4m - Total Current Liabilities 216.0m) / Total Assets 3.37b |
| (B) 0.27 = Retained Earnings (Balance) 905.8m / Total Assets 3.37b |
| (C) 0.03 = EBIT TTM 109.3m / Avg Total Assets 3.25b |
| (D) 0.58 = Book Value of Equity 969.7m / Total Liabilities 1.67b |
| Total Rating: 2.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.20
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 3.36% = 1.68 |
| 3. FCF Margin 9.17% = 2.29 |
| 4. Debt/Equity 0.71 = 2.25 |
| 5. Debt/Ebitda 6.16 = -2.50 |
| 6. ROIC - WACC -1.81% = -2.26 |
| 7. RoE 5.05% = 0.42 |
| 8. Rev. Trend 95.78% = 7.18 |
| 9. EPS Trend 82.64% = 4.13 |
What is the price of ITGR shares?
Over the past week, the price has changed by -2.32%, over one month by -2.34%, over three months by -12.90% and over the past year by -19.39%.
Is Integer Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ITGR is around 94.40 USD . This means that ITGR is currently overvalued and has a potential downside of -8.41%.
Is ITGR a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ITGR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 140.9 | 36.7% |
| Analysts Target Price | 140.9 | 36.7% |
| ValueRay Target Price | 102 | -1% |
Last update: 2025-09-05 04:48
ITGR Fundamental Data Overview
CCE Cash And Equivalents = 23.1m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 45.2308
P/E Forward = 17.0068
P/S = 2.066
P/B = 2.1767
P/EG = 0.6539
Beta = 1.021
Revenue TTM = 1.79b USD
EBIT TTM = 109.3m USD
EBITDA TTM = 196.8m USD
Long Term Debt = 1.20b USD (from longTermDebt, last quarter)
Short Term Debt = 8.92m USD (from shortTermDebt, last quarter)
Debt = 1.21b USD (Calculated: Short Term 8.92m + Long Term 1.20b)
Net Debt = 1.30b USD (from netDebt column, last quarter)
Enterprise Value = 4.90b USD (3.71b + Debt 1.21b - CCE 23.1m)
Interest Coverage Ratio = 2.13 (Ebit TTM 109.3m / Interest Expense TTM 51.3m)
FCF Yield = 3.36% (FCF TTM 164.5m / Enterprise Value 4.90b)
FCF Margin = 9.17% (FCF TTM 164.5m / Revenue TTM 1.79b)
Net Margin = 4.61% (Net Income TTM 82.7m / Revenue TTM 1.79b)
Gross Margin = 26.90% ((Revenue TTM 1.79b - Cost of Revenue TTM 1.31b) / Revenue TTM)
Tobins Q-Ratio = 5.05 (Enterprise Value 4.90b / Book Value Of Equity 969.7m)
Interest Expense / Debt = 0.81% (Interest Expense 9.75m / Debt 1.21b)
Taxrate = 17.97% (26.5m / 147.6m)
NOPAT = 89.7m (EBIT 109.3m * (1 - 17.97%))
Current Ratio = 3.41 (Total Current Assets 737.4m / Total Current Liabilities 216.0m)
Debt / Equity = 0.71 (Debt 1.21b / last Quarter total Stockholder Equity 1.70b)
Debt / EBITDA = 6.16 (Net Debt 1.30b / EBITDA 196.8m)
Debt / FCF = 7.36 (Debt 1.21b / FCF TTM 164.5m)
Total Stockholder Equity = 1.64b (last 4 quarters mean)
RoA = 2.45% (Net Income 82.7m, Total Assets 3.37b )
RoE = 5.05% (Net Income TTM 82.7m / Total Stockholder Equity 1.64b)
RoCE = 3.85% (Ebit 109.3m / (Equity 1.64b + L.T.Debt 1.20b))
RoIC = 3.24% (NOPAT 89.7m / Invested Capital 2.76b)
WACC = 5.05% (E(3.71b)/V(4.92b) * Re(6.49%)) + (D(1.21b)/V(4.92b) * Rd(0.81%) * (1-Tc(0.18)))
Shares Correlation 3-Years: 78.79 | Cagr: 0.63%
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈124.7m ; Y1≈153.8m ; Y5≈262.5m
Fair Price DCF = 127.4 (DCF Value 4.46b / Shares Outstanding 35.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 82.64 | EPS CAGR: 19.48% | SUE: 0.16 | # QB: False
Revenue Correlation: 95.78 | Revenue CAGR: 12.74%
Additional Sources for ITGR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle